ArticleParasites & vectors2026
Morphological and molecular characterization of Sarcocystis chenggongensis n. sp. (Apicomplexa: Sarcocystidae) in domestic sheep (Ovis aries) from China.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundInfections with Sarcocystis spp. in sheep (Ovis aries) are globally prevalent and pose significant health and economic concerns. Nine Sarcocystis taxa, comprising seven identified species and two unclassified entities, are known to form sarcocysts in sheep. Macroscopic sarcocysts with elongated villar protrusions are rare, having been reported only twice: as S. mihoensis in Japan and as an S. mihoensis -like organism in Spain. This study reports the first identification of this morphological type in China.
methodsMuscle samples were collected from 83 domestic sheep in Kunming City, China, between March and September 2025. Sarcocysts were characterized morphologically using light microscopy (LM) and transmission electron microscopy (TEM). For molecular analysis, genomic DNA was extracted from individual sarcocysts isolated from different sheep. Five genetic markers-the nuclear 18S rDNA, 28S rDNA, and ITS-1 regions, the mitochondrial cox1 gene, and the apicoplast rpoB gene-were amplified, sequenced, and analyzed.
resultsA novel sarcocyst type was detected via LM in 6 out of 83 (7.2%) domestic sheep. These macroscopic sarcocysts measured up to 6230 μm in length and 341 μm in width, and possessed a thick cyst wall with numerous sloping villar protrusions (VPs) measuring 6.9-11.9 μm in length. Ultrastructurally, the VPs were 5.8-9.3 μm long and 0.8-1.1 μm wide, lined by an electron-dense layer, and contained scattered microtubules that extended from the apex to the base. Sequence comparisons with GenBank entries revealed the highest sequence similarities with S. buffalonis for 18S rDNA (97.6-98.0%), S. miescheriana for 28S rDNA (92.1-92.3%), S. japonica for cox1 (81.2-81.8% identity), and S. arctica for rpoB (88.5-88.8% identity). No significant matches were found for the ITS-1 region. Genetic divergence analysis against other sheep-infecting species indicated the smallest distances with S. medusiformis at 18S rDNA (0.0582), S. gigantea at 28S rDNA (0.0556), and S. gigantea at cox1 (0.2922). Given the distinct morphological features and the unique molecular characteristics, this organism is proposed as a new species, Sarcocystis chenggongensis n. sp.
conclusionsThe discovery of this new species marks the third global report of macroscopic sarcocysts with elongated villar protrusions, confirming a broad geographical distribution for this rare morphotype. Persistent taxonomic uncertainties, due to inconsistent data, require future research to resolve the group's evolution and life cycles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.